390 related articles for article (PubMed ID: 32521494)
1. Abscopal effect in radioimmunotherapy.
Ashrafizadeh M; Farhood B; Eleojo Musa A; Taeb S; Rezaeyan A; Najafi M
Int Immunopharmacol; 2020 Aug; 85():106663. PubMed ID: 32521494
[TBL] [Abstract][Full Text] [Related]
2. Immune mechanisms mediating abscopal effects in radioimmunotherapy.
Rodriguez-Ruiz ME; Rodriguez I; Leaman O; López-Campos F; Montero A; Conde AJ; Aristu JJ; Lara P; Calvo FM; Melero I
Pharmacol Ther; 2019 Apr; 196():195-203. PubMed ID: 30529041
[TBL] [Abstract][Full Text] [Related]
3. TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies.
Rodríguez-Ruiz ME; Rodríguez I; Mayorga L; Labiano T; Barbes B; Etxeberria I; Ponz-Sarvise M; Azpilikueta A; Bolaños E; Sanmamed MF; Berraondo P; Calvo FA; Barcelos-Hoff MH; Perez-Gracia JL; Melero I
Mol Cancer Ther; 2019 Mar; 18(3):621-631. PubMed ID: 30683810
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade.
Zhao X; Shao C
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992835
[TBL] [Abstract][Full Text] [Related]
5. Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives.
Mortezaee K; Najafi M
Crit Rev Oncol Hematol; 2021 Jan; 157():103180. PubMed ID: 33264717
[TBL] [Abstract][Full Text] [Related]
6. Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications.
Popp I; Grosu AL; Niedermann G; Duda DG
Radiother Oncol; 2016 Aug; 120(2):185-94. PubMed ID: 27495145
[TBL] [Abstract][Full Text] [Related]
7. Radiation Therapy and Immune Modulation.
Leeman JE; Schoenfeld JD
Hematol Oncol Clin North Am; 2019 Apr; 33(2):233-248. PubMed ID: 30832997
[TBL] [Abstract][Full Text] [Related]
8. The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches.
Tubin S; Yan W; Mourad WF; Fossati P; Khan MK
Future Oncol; 2020 Jun; 16(16):1137-1151. PubMed ID: 32338046
[TBL] [Abstract][Full Text] [Related]
9. Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model.
Basler L; Kowalczyk A; Heidenreich R; Fotin-Mleczek M; Tsitsekidis S; Zips D; Eckert F; Huber SM
Cancer Immunol Immunother; 2018 Apr; 67(4):653-662. PubMed ID: 29335856
[TBL] [Abstract][Full Text] [Related]
10. PD-1 Restrains Radiotherapy-Induced Abscopal Effect.
Park SS; Dong H; Liu X; Harrington SM; Krco CJ; Grams MP; Mansfield AS; Furutani KM; Olivier KR; Kwon ED
Cancer Immunol Res; 2015 Jun; 3(6):610-9. PubMed ID: 25701325
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations.
Karapetyan L; Iheagwara UK; Olson AC; Chmura SJ; Skinner HK; Luke JJ
J Natl Cancer Inst; 2023 Nov; 115(11):1278-1293. PubMed ID: 37348864
[TBL] [Abstract][Full Text] [Related]
12. The optimism surrounding stereotactic body radiation therapy and immunomodulation.
Tharmalingam H; Hoskin PJ
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S9. PubMed ID: 28917247
[TBL] [Abstract][Full Text] [Related]
13. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
14. Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.
Dudzinski SO; Cameron BD; Wang J; Rathmell JC; Giorgio TD; Kirschner AN
J Immunother Cancer; 2019 Aug; 7(1):218. PubMed ID: 31412954
[TBL] [Abstract][Full Text] [Related]
15. Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.
Ishihara D; Pop L; Takeshima T; Iyengar P; Hannan R
Cancer Immunol Immunother; 2017 Mar; 66(3):281-298. PubMed ID: 27743027
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced bystander and abscopal effects: important lessons from preclinical models.
Daguenet E; Louati S; Wozny AS; Vial N; Gras M; Guy JB; Vallard A; Rodriguez-Lafrasse C; Magné N
Br J Cancer; 2020 Aug; 123(3):339-348. PubMed ID: 32581341
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control.
Rodriguez-Ruiz ME; Serrano-Mendioroz I; Garate-Soraluze E; Sánchez-Mateos P; Barrio-Alonso C; Rodríguez López I; Diaz Pascual V; Arbea Moreno L; Alvarez M; Sanmamed MF; Perez-Gracia JL; Escuin-Ordinas H; Quintero M; Melero I
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36631161
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy and radiotherapy].
Bockel S; Antoni D; Deutsch É; Mornex F
Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
[TBL] [Abstract][Full Text] [Related]
19. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
[TBL] [Abstract][Full Text] [Related]
20. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8
Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C
Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
